OpenAlex
PricingAboutJobs
Log inGet started
Work

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(10)62318-5
Authors: Klemens Budde, Thomas Becker, Wolfgang Arns, Claudia Sommerer, Petra Reinke, Ute Eisenberger, Stefan Kramer, Wolfgang Fischer, Harald Gschaidmeier, Frank Pietruck
Institutions: Charité – Universitätsmedizin Berlin, Medizinische Hochschule Hannover, Heidelberg University, University of Bern, University Hospital of Bern, Novartis (Germany), Novartis (Switzerland), Essen University Hospital, University of Duisburg-Essen
Language: English

Topic: Renal Transplantation Outcomes and Treatments
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Keywords: everolimus, calcineurin inhibitor-free immunosuppression, kidney transplantation, cyclosporine, mycophenolate mofetil, tacrolimus, tacrolimus trough levels, glomerular filtration rate, renal graft function, immunosuppression, tacrolimus withdrawal, tacrolimus dose reduction
SDG: Good health and well-being

Open Access status: closed

Funders: Novartis, Astellas Pharma, Novartis Pharma
OpenAlex ID: W2108565052
FWCI: 31.5
Cites: 34
Cited by: 393
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms